Sysmex (OTCMKTS:SSMXY) Sets New 12-Month Low - What's Next?

Key Points

• Sysmex Corporation's stock has hit a new 52-week low at $12.67, having last traded at $12.93 with a volume of 183,439 shares.
• The company reported earnings per share (EPS) of $0.05 for the last quarter, missing the consensus estimate of $0.12, and had revenue of $717.09 million, lower than analysts' expectations of $807.27 million.
• Despite recent struggles, Zacks Research has updated Sysmex's rating from a "strong sell" to a "hold," with a consensus rating of "hold" from analysts.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price reached a new 52-week low on Tuesday . The stock traded as low as $12.67 and last traded at $12.93, with a volume of 183439 shares changing hands. The stock had previously closed at $13.36.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Sysmex from a "strong sell" rating to a "hold" rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of "Hold".

Sysmex Price Performance

The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37. The company has a market cap of $7.91 billion, a PE ratio of 25.14 and a beta of 1.10. The company's 50-day simple moving average is $15.64 and its 200 day simple moving average is $17.17.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The business had revenue of $717.09 million during the quarter, compared to analysts' expectations of $807.27 million. On average, sell-side analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.